Submit Your Manuscript
Join the global oncology community advancing cancer research and patient care.
Publish Your Cancer Research with Impact
Journal of Neoplasms welcomes mechanistic, translational, and clinical research across all areas of oncology. Our streamlined submission process and expert peer review ensure your work reaches the global cancer research community with maximum visibility.
Rapid peer review. Open access publishing. Global readership.
Original Research
Clinical trials, translational studies, and mechanistic research with validated methodology (5,000-8,000 words).
Reviews
Comprehensive syntheses of molecular pathways, clinical evidence, and therapeutic advances (6,000-10,000 words).
Case Reports
Instructive cases with novel findings, diagnostic challenges, or treatment insights (2,000-3,000 words).
Short Communications
Rapid reports of significant mechanistic, translational, or clinical findings (2,000-3,000 words).
Online Portal
Submit through ManuscriptZone for full tracking, revision management, and direct communication with editors.
Quick Submission
Use our Simple Submission Form for faster initial submission without portal registration.
Email Submission
Send manuscripts directly to [email protected]. Our team will register your submission in the portal.
- Title Page: Manuscript title, all author names, affiliations, and corresponding author contact
- Abstract: Structured summary (Background, Methods, Results, Conclusions) under 300 words
- Keywords: 5-8 terms for indexing and discoverability
- Main Text: Clear sections with headings, properly cited references
- Figures and Tables: High-resolution (300+ DPI), numbered, with descriptive captions
- References: Complete citations with DOIs where available
- Ethics Statement: IRB/IACUC approval, informed consent, data availability
- Disclosures: Competing interests and funding sources for all authors
Initial Screening
Editorial assessment of scope fit, completeness, and quality standards.
2-3 daysPeer Review
Expert evaluation by oncology specialists for methodology, rigor, and clinical relevance.
14-18 daysDecision and Revision
Editorial decision with reviewer feedback. Authors address comments and resubmit.
5-7 daysProduction and Publication
Copyediting, typesetting, proofs, DOI registration, and online publication.
5-7 daysOpen Access Advantage: All accepted articles are published under CC BY 4.0 license, ensuring maximum visibility and reuse. APCs apply after acceptance. View APC details or contact [email protected] for membership discounts.
Ready to Submit?
Share your cancer research with the global oncology community.
